Peak Perform Innova has announced the completion of nearly 100 million yuan in angel round financing. This round of funding was co-led by Huagai Capital and Boyuan Capital, with participation from the angel fund and others. The financing will primarily be used to accelerate the preclinical candidate molecule development and IND application for the STAT6 project, advance the IND application for the core pipeline of the degradant PPI-101; and expedite the rapid optimization and iteration of the AI drug development platform based on Protein-Protein Interaction (PPI).